|
|
|
CPhI India |
|
 |
1-3 December 2010
Mumbai, India
With the Indian market fast becoming a major global economy and with its pharmaceutical market expected to treble over the years to 2015, CPhI India 2009 is a unique chance to link up with the very best in this industry as they gather to discuss the key issues, trends and developments in one location.
Generate new alliances, renew existing partnerships and benefit from the dynamic networking opportunities available to actively drive your business forward. Attend CPhI India 2009 – the perfect environment for growth.
For more information please contact the sales department at: +31 (0) 20 409 9505 or send an email to: martin.wilson@ubm.com
http://www.cphi-india.com/ |
 |
 |
 |
|
|
|
|
 |
Industry Events |
 |
Pharmapack Europe 2012
15-16 February 2012, Grande Halle de la Villette, Paris, France
Confirming its continuous expansion, the show will welcome a higher number of participants than last year, with 2,800 visitors from 50 countries expected to join the 250 exhibitors at the Grande Halle de la Villette.
More info >> |
|
 |
News and Press Releases |
 |
AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
AMRI, a global contract services organization, announced today that it has entered into a preferred provider agreement with BioPontis Alliance LLC. The agreement is aimed at supporting BioPontis’ mission to bridge the gap between early-stage research and technologies being discovered and developed in academia and other research entities. AMRI will provide its services in small molecule discovery, development, and manufacturing in BioPontis’ drug discovery research programs. The agreement also supports the need for proof-of-concept data that is required in the current pharmaceutical company licensing environment. The goal of BioPontis Alliance is to identify promising early stage product opportunities and utilize a preferred network of CROs and leading research companies to apply appropriate expertise to develop these opportunities enough to attract pharmaceutical company licensing partners.
More info >> |
|
|